Abstract
SummaryMucosal pathogens target sites of infection through specific adherence to host glycoconjugate receptors. As a consequence, depletion of such receptors from the cell surface may be expected to inhibit attachment, impair bacterial colonization and reduce the activation of mucosal inflammation. We have used the glucose analogue and glycosphingolipid (GSL) biosynthesis inhibitor N‐butyldeoxynojirimycin (NB‐DNJ) to deplete human uroepithelial cells and the murine urinary tract mucosa of receptors for P‐fimbriated Escherichia coli. NB‐DNJ blocks the ceramide‐specific glucosyltransferase, which catalyses the formation of glucosyl ceramide (GlcCer), the precursor for GSLs. The inhibitor was shown to decrease the GSL content in a dose‐dependent way, and depletion markedly inhibited P‐fimbriated bacterial attachment in vitro. NB‐DNJ‐fed C3H/HeN mice were depleted of GSLs in vivo and showed reduced susceptibility to experimental urinary tract infection with P‐fimbriated E. coli. The mucosal inflammatory response was impaired, as shown by reduced chemokine secretion and lower neutrophil recruitment, and the bacteria colonized the urinary tract less efficiently than in normal mice. These results confirmed the role of P fimbriae‐mediated adherence for colonization and inflammation and point to an interesting alternative to antibiotic treatment for urinary tract infection.
References
43
Referenced
33
10.1172/JCI116650
10.1016/0003-9861(86)90350-4
10.1016/S0021-9258(17)39507-8
/ J Biol Chem / Specificity of binding of a strain of uropathogenic Escherichia coli to Galα1–4Galβ containing glycosphingolipids by Bock K. (1985)10.1084/jem.176.5.1311
10.1128/iai.38.2.739-744.1982
/ Infect Immun / Cloning of genes determining the production of mannose‐resistant fimbriae in a uropathogenic strain of Escherichia coli belonging to serogroup O6 by Clegg S. (1982)10.1016/S0140-6736(00)02161-9
10.1016/0378-1097(83)90363-4
10.1128/jvi.70.10.7143-7152.1996
10.1084/jem.192.6.881
10.1046/j.1365-2958.2001.02361.x
10.1093/oxfordjournals.aje.a114050
10.1128/iai.40.1.273-283.1983
/ Infect Immun / Ascending, unobstructed urinary tract infection in mice caused by pyelonephritic Escherichia coli of human origin by Hagberg L. (1983)10.1128/iai.59.1.421-427.1991
/ Infect Immun / Interleukin‐6 response to deliberate colonisation of the human urinary tract with gram‐negative bacteria by Hedges S. (1991)10.1084/jem.183.3.1037
10.1046/j.1365-2958.1998.01017.x
10.1007/978-1-4614-4614-9_13
10.1073/pnas.96.11.6388
10.1128/CMR.4.1.80
10.1093/glycob/11.2.11R
10.1007/BF00330751
10.1126/science.276.5312.607
10.1111/j.1574-6968.1980.tb05064.x
10.1128/IAI.34.3.920-929.1981
10.1128/iai.57.11.3389-3394.1989
/ Infect Immun / Binding specificities of wild‐type and cloned Escherichia coli strains recognize globo‐A by Lindstedt R. (1989)10.1128/iai.59.3.1086-1092.1991
/ Infect Immun / The receptor repertoire defines the host range for attaching Escherichia coli strains that recognize globo‐A by Lindstedt R. (1991)10.1056/NEJM198305193082003
{'key': 'e_1_2_6_28_1', 'volume-title': 'Microbial Lectins and Agglutinins: Properties and Biological Activity', 'author': 'Mirelman D.', 'year': '1986'}
/ Microbial Lectins and Agglutinins: Properties and Biological Activity by Mirelman D. (1986){'key': 'e_1_2_6_29_1', 'first-page': '421', 'article-title': 'New therapeutic prospects for the glycosphingolipid lysosomal storage diseases', 'volume': '15', 'author': 'Platt F.M.', 'year': '1998', 'journal-title': 'Biochem Pharmacol'}
/ Biochem Pharmacol / New therapeutic prospects for the glycosphingolipid lysosomal storage diseases by Platt F.M. (1998)10.1016/S0021-9258(18)47132-3
/ J Biol Chem / N‐butyldeoxygalactonojirimicin inhibits glycolipid biosynthesis but does not affect N‐linked oligosaccharide processing by Platt F.M. (1994)10.1016/S0021-9258(17)37202-2
10.1126/science.276.5311.428
10.1074/jbc.272.31.19365
10.1093/infdis/171.3.625
10.1007/BF00731489
10.1016/S0079-6123(08)61937-8
10.1016/S0021-9258(19)45358-1
10.1016/S1369-5274(99)80017-4
10.1016/S0140-6736(76)90788-1
10.1128/IAI.62.10.4404-4410.1994
10.1016/S0140-6736(81)92796-3
10.1146/annurev.bi.56.070187.002053
10.1046/j.1365-2958.2000.02165.x
10.1046/j.1462-5822.2001.00111.x
Dates
Type | When |
---|---|
Created | 22 years, 5 months ago (March 12, 2003, 6:47 a.m.) |
Deposited | 1 year, 10 months ago (Oct. 14, 2023, 11:13 a.m.) |
Indexed | 2 months ago (July 1, 2025, 8:47 a.m.) |
Issued | 22 years, 8 months ago (Jan. 1, 2003) |
Published | 22 years, 8 months ago (Jan. 1, 2003) |
Published Online | 22 years, 7 months ago (Jan. 10, 2003) |
Published Print | 22 years, 8 months ago (Jan. 1, 2003) |
@article{Svensson_2003, title={Glycolipid depletion in antimicrobial therapy}, volume={47}, ISSN={1365-2958}, url={http://dx.doi.org/10.1046/j.1365-2958.2003.03306.x}, DOI={10.1046/j.1365-2958.2003.03306.x}, number={2}, journal={Molecular Microbiology}, publisher={Wiley}, author={Svensson, Majlis and Frendeus, Björn and Butters, Terry and Platt, Frances and Dwek, Raymond and Svanborg, Catharina}, year={2003}, month=jan, pages={453–461} }